Phyrago
Payments companies reported to CMS as associated with Phyrago. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Phyrago, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Phyrago
These are the largest totals companies reported as associated with Phyrago. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hagop Kantarjian | Houston, TX | Medical Oncology | $3,500.00 |
| Javier Pinilla-Ibarz | Tampa, FL | Hematology (Internal Medicine) | $2,013.68 |
| Shira Dinner | Chicago, IL | Hematology & Oncology | $1,900.00 |
| Jorge Cortes-Franco | Houston, TX | Hematology & Oncology | $1,900.00 |
| Tiffany Tanaka | San Diego, CA | Hematology & Oncology | $1,700.00 |
| Anthony Hunter | Atlanta, GA | Hematology & Oncology | $1,700.00 |
| Anand Patel | Chicago, IL | Hematology & Oncology | $1,700.00 |
| Afaf Osman | Chicago, IL | Hematology & Oncology | $1,550.00 |
| Rebecca Kirschner | Spokane, WA | Surgical Oncology | $245.22 |
| Lisa Nodzon | Tampa, FL | Nurse Practitioner | $113.69 |
Prescribed Phyrago?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.